Barclays Positive on BridgeBio Pharma (BBIO): 'We expect continued strength from Attruby launch'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/9/2026

1. SPY
2. AAPL
3. NVDA
4. USO
5. BXDC
6. CPB
7. FRVO
8. PEGA
9. LLY
10. CBRS

Go back to Barclays Positive on BridgeBio Pharma (BBIO): 'We expect continued strength from Attruby launch'
(NASDAQ: BBIO) Delayed: 67.37 -0.24 (0.35%)
Previous Close $67.61    52 Week High $ 
Open $67.97    52 Week Low $ 
Day High $68.43    P/E N/A 
Day Low $66.76    EPS $ 
Volume 1,751,908